Publication | Open Access
Tumor Microenvironment Cascade Activated Biodegradable Nano‐Enzymes for Glutathione‐Depletion and Ultrasound‐Enhanced Chemodynamic Therapy
12
Citations
46
References
2024
Year
Chemodynamic therapy (CDT) is emerged as a novel and promising tumor therapy by using the powerful reactive oxygen species (ROS) to kill cancer cells. However, the current CDT is remarkably inhibited due to insufficient H<sub>2</sub>O<sub>2</sub> supply and over-expression of glutathione (GSH) in the tumor microenvironment (TME). Herein, a biodegradable self-supplying H<sub>2</sub>O<sub>2</sub> nano-enzyme of CuO<sub>2</sub>@CaP with a GSH-consumption effect is designed for cascade enhanced CDT to overcome the problem of H<sub>2</sub>O<sub>2</sub> deficiency and GSH overexpression. In this design, CuO<sub>2</sub>@CaP is gradually degraded to Ca<sup>2+</sup>, Cu<sup>2+</sup>, and H<sub>2</sub>O<sub>2</sub> in acidic TME, resulting in synergistically enhanced CDT owing to the efficient self-supplied H<sub>2</sub>O<sub>2</sub> and GSH-depletion and Ca<sup>2+</sup> overload therapy. Interestingly, the faster degradation of CuO<sub>2</sub>@CaP and promoted production rate of •OH are further achieved after triggering with ultrasound (US). And, the US-enhanced CDT and Ca<sup>2+</sup> overload synergistic antitumor therapy is successfully achieved in vivo. These findings provide a promising strategy for designing biodegradable nano-enzymes with self-supplying H<sub>2</sub>O<sub>2</sub> and GSH consumption for US-mediated CDT.
| Year | Citations | |
|---|---|---|
Page 1
Page 1